Immunization Schedule Calculator

Childhood immunization is one of the most thoroughly studied and consequential medical interventions in human history, preventing an estimated 4 million deaths worldwide every year and effectively eliminating diseases that once killed or disabled millions of children annually. The first hepatitis B dose is recommended within 24 hours of birth, beginning a vaccination schedule that protects against 14 different diseases before a child's second birthday. Understanding which vaccines are given at each age, what they protect against, and how the schedule was developed helps parents approach immunization appointments with confidence and clarity about why the timing matters.

Twelve-Month Vaccines: Live Virus Protection

The 12-month visit introduces live attenuated virus vaccines that could not be given earlier because maternal antibodies would neutralize the weakened vaccine viruses before they could stimulate immunity. MMR (measles, mumps, and rubella) is administered at 12 to 15 months, with a second dose at 4 to 6 years. Measles remains one of the most contagious diseases known, and the MMR vaccine is approximately 97 percent effective after two doses.

Varicella (chickenpox) vaccine is also given at 12 to 15 months, with a second dose at 4 to 6 years. Before routine vaccination in 1995, chickenpox infected approximately 4 million Americans annually, hospitalizing 10,000 and killing 100 to 150. Some parents who remember chickenpox as a mild childhood illness underestimate its potential severity, but complications including bacterial skin infections, pneumonia, and encephalitis made it far more dangerous than popular memory suggests. The vaccine is 90 percent effective at preventing any chickenpox and 98 percent effective against severe disease. Hepatitis A vaccine begins at 12 months with two doses given 6 months apart.

Understanding Combination Vaccines and Scheduling

Modern combination vaccines reduce the number of injections while providing the same protection. Vaxelis combines DTaP, IPV, Hib, and hepatitis B into a single shot. The CDC schedule spaces vaccines at minimum intervals necessary for effective immune response while providing protection as early as possible. These intervals reflect decades of immunological research.

Alternative or delayed schedules have not been shown to improve safety outcomes and demonstrably increase vulnerability to vaccine-preventable diseases. A study in Pediatrics analyzing over 500,000 children found no association between the number of vaccine antigens received on a single day and adverse outcomes. The infant immune system routinely encounters far more antigens from environmental exposure than from the entire vaccine schedule combined.

The Birth Dose and First Two Months

The hepatitis B vaccine is the only immunization administered at birth, ideally within the first 24 hours of life. Newborns who contract hepatitis B have a 90 percent chance of developing chronic infection compared to only 5 percent for adults. The birth dose provides immediate protection during the vulnerable newborn period, and the vaccine uses a recombinant protein rather than live virus, making it safe for even the smallest premature infants.

The first major immunization appointment occurs at 2 months, when babies receive DTaP (diphtheria, tetanus, and pertussis), IPV (inactivated polio), Hib (Haemophilus influenzae type b), PCV15 or PCV20 (pneumococcal conjugate), and rotavirus oral vaccine. The visit typically involves 3 injections and 1 oral dose, as several vaccines are combined into single shots. Pediarix, for example, combines DTaP, IPV, and hepatitis B into one injection.

Rotavirus vaccine deserves particular mention because it is administered orally rather than by injection. Rotavirus was the leading cause of severe infant diarrhea worldwide before vaccination, hospitalizing approximately 55,000 American children annually. The vaccine comes in either a 2-dose series (Rotarix, given at 2 and 4 months) or a 3-dose series (RotaTeq, given at 2, 4, and 6 months). The first dose must be given before 15 weeks of age, making timely vaccination particularly important for this vaccine.

Fifteen to Eighteen Months: Boosters and Completion

The fourth dose of DTaP, given between 12 and 18 months, boosts pertussis immunity to approximately 85 to 90 percent, significantly higher than the 60 to 70 percent from the initial three doses. The Hib booster completes the series for a vaccine that reduced invasive Haemophilus influenzae disease by over 99 percent since its introduction. PCV receives its booster as well, having reduced invasive pneumococcal disease in children under 5 by approximately 90 percent since 2000.

By 18 months, most children have received the majority of their infant and toddler vaccines. The intensive vaccine schedule of the first 18 months reflects the vulnerability of young children to serious infections and the immune system's need for multiple exposures to build durable protection. The remaining childhood immunizations on the CDC schedule include second doses of MMR and varicella between ages 4 and 6, and Tdap, HPV, and meningococcal vaccines during adolescence.

Related Calculators

• Baby Milestone Calculator
• Baby Growth Percentile Calculator

The Four-Month and Six-Month Visits

The 4-month visit largely mirrors the 2-month visit, administering second doses of DTaP, IPV, Hib, PCV, and rotavirus. These repeated doses are essential for building robust immunity because the immune system of a 2-month-old responds less vigorously to vaccine antigens than an older child's. Sequential doses stimulate increasingly strong immune responses through a process called priming and boosting.

The 6-month visit adds the third dose of DTaP, the third dose of PCV, and the third hepatitis B dose. Influenza vaccine also becomes recommended at this age, with the first-ever flu vaccination requiring two doses spaced 4 weeks apart. The 6-month mark is important because completion of the primary DTaP series provides substantial pertussis protection, which is why the CDC recommends pregnant women receive Tdap between 27 and 36 weeks of gestation to maximize antibody transfer to the fetus.

Side effects from the 2, 4, and 6-month vaccines are generally mild and self-limiting. The most common reactions include fussiness lasting 24 to 48 hours, low-grade fever below 101 degrees Fahrenheit, redness and swelling at injection sites, and decreased appetite for one to two days. These reactions indicate that the immune system is responding to the vaccine antigens, which is exactly the intended effect. Acetaminophen can be given after vaccination if the baby is uncomfortable, though routine pre-dosing before the appointment is no longer recommended because some research suggests it may slightly diminish the immune response.

Catch-Up Schedules and Common Concerns

Children who miss scheduled doses do not need to restart from the beginning. The immune system retains memory of previous vaccine exposures, and catch-up doses can resume the series from where it left off. The CDC publishes detailed catch-up schedules specifying minimum intervals between doses for children who have fallen behind, allowing providers to develop personalized plans. Catch-up vaccination is particularly important before children enter group childcare settings, where exposure to infectious diseases increases dramatically. Most states require proof of age-appropriate vaccination for daycare and school enrollment.

Fever after vaccination, occurring in 10 to 25 percent of infants, typically appears within 6 to 24 hours, rarely exceeds 102 degrees, and resolves within 48 hours. Thimerosal was removed from all childhood vaccines except multi-dose flu vials by 2001. Aluminum adjuvants are present in smaller quantities than what infants ingest from breast milk and food. The relationship between vaccines and autism has been investigated in studies involving millions of children across multiple countries, and no association has been found. The original 1998 study was retracted for containing fraudulent data, and its author lost his medical license. The scientific consensus on vaccine safety is as robust as it is for any medical intervention in widespread use.